APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood & Tissue Kit

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Blood & Tissue Kit Market Outlook and Growth Opportunities 2026

30 December 2025202 pages

Choose your research edition.

Industry ResearchBlood & Tissue Kit Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood & Tissue Kit Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Blood & Tissue Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood & Tissue Kit Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood & Tissue Kit Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Blood & Tissue Kit market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Blood & Tissue Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood & Tissue Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood & Tissue Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Blood & Tissue Kit market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Blood & Tissue Kit market include QIAGEN, Analytik Jena, Axygen (Corning), Bio-Rad, BioVision, Geneaid, Illumina, Lucigen (Biosearch Technologies) and Macherey-Nagel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Blood & Tissue Kit market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood & Tissue Kit and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood & Tissue Kit sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blood & Tissue Kit market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood & Tissue Kit Segment by Company

QIAGEN

Analytik Jena

Axygen (Corning)

Bio-Rad

BioVision

Geneaid

Illumina

Lucigen (Biosearch Technologies)

Macherey-Nagel

Norgen

Omega Bio-tek

Promega

Sigma-Aldrich (Merck)

Zymo Research

MGI Tech Co., Ltd.

Roche

Thermo Fisher Scientific

Blood & Tissue Kit Segment by Type

Buffy Coat

Whole Blood

Plasma or Serum

Blood & Tissue Kit Segment by Application

R&D Organisations

Biotechnology Companies

Blood & Tissue Kit Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Blood & Tissue Kit status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Blood & Tissue Kit market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blood & Tissue Kit significant trends, drivers, influence factors in global and regions.

6. To analyze Blood & Tissue Kit competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood & Tissue Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood & Tissue Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood & Tissue Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Blood & Tissue Kit market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood & Tissue Kit industry.

Chapter 3: Detailed analysis of Blood & Tissue Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Blood & Tissue Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Blood & Tissue Kit in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blood & Tissue Kit Industry Trends Table 2. Blood & Tissue Kit Industry Drivers Table 3. Blood & Tissue Kit Industry Opportunities and Challenges Table 4. Blood & Tissue Kit Industry Restraints Table 5. Global Blood & Tissue Kit Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blood & Tissue Kit Revenue Share by Company (2021-2026) Table 7. Global Blood & Tissue Kit Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Blood & Tissue Kit Sales Volume Share by Company (2021-2026) Table 9. Global Blood & Tissue Kit Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Blood & Tissue Kit Company Ranking, (2024-2026) & (USD Million) Table 11. Global Blood & Tissue Kit Key Company Manufacturing Base & Headquarters Table 12. Global Blood & Tissue Kit Company, Product Type & Application Table 13. Global Blood & Tissue Kit Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Blood & Tissue Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Buffy Coat Table 18. Significant Companies of Whole Blood Table 19. Significant Companies of Plasma or Serum Table 20. Global Blood & Tissue Kit Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Blood & Tissue Kit Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Blood & Tissue Kit Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Blood & Tissue Kit Sales Volume Share by Type (2021-2026) Table 24. Global Blood & Tissue Kit Sales Volume Share by Type (2027-2032) Table 25. Global Blood & Tissue Kit Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Blood & Tissue Kit Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Blood & Tissue Kit Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Blood & Tissue Kit Sales Value Share by Type (2021-2026) Table 29. Global Blood & Tissue Kit Sales Value Share by Type (2027-2032) Table 30. Significant Companies of R&D Organisations Table 31. Significant Companies of Biotechnology Companies Table 32. Global Blood & Tissue Kit Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Blood & Tissue Kit Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Blood & Tissue Kit Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Blood & Tissue Kit Sales Volume Share by Application (2021-2026) Table 36. Global Blood & Tissue Kit Sales Volume Share by Application (2027-2032) Table 37. Global Blood & Tissue Kit Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Blood & Tissue Kit Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Blood & Tissue Kit Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Blood & Tissue Kit Sales Value Share by Application (2021-2026) Table 41. Global Blood & Tissue Kit Sales Value Share by Application (2027-2032) Table 42. Global Blood & Tissue Kit Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Blood & Tissue Kit Sales by Region (2021-2026) & (K Units) Table 44. Global Blood & Tissue Kit Sales Market Share by Region (2021-2026) Table 45. Global Blood & Tissue Kit Sales by Region (2027-2032) & (K Units) Table 46. Global Blood & Tissue Kit Sales Market Share by Region (2027-2032) Table 47. Global Blood & Tissue Kit Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Blood & Tissue Kit Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Blood & Tissue Kit Sales Value Share by Region (2021-2026) Table 50. Global Blood & Tissue Kit Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Blood & Tissue Kit Sales Value Share by Region (2027-2032) Table 52. Global Blood & Tissue Kit Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Blood & Tissue Kit Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Blood & Tissue Kit Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Blood & Tissue Kit Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Blood & Tissue Kit Sales by Country (2021-2026) & (K Units) Table 57. Global Blood & Tissue Kit Sales Market Share by Country (2021-2026) Table 58. Global Blood & Tissue Kit Sales by Country (2027-2032) & (K Units) Table 59. Global Blood & Tissue Kit Sales Market Share by Country (2027-2032) Table 60. Global Blood & Tissue Kit Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Blood & Tissue Kit Sales Value Market Share by Country (2021-2026) Table 62. Global Blood & Tissue Kit Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Blood & Tissue Kit Sales Value Market Share by Country (2027-2032) Table 64. QIAGEN Company Information Table 65. QIAGEN Business Overview Table 66. QIAGEN Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. QIAGEN Blood & Tissue Kit Product Portfolio Table 68. QIAGEN Recent Development Table 69. Analytik Jena Company Information Table 70. Analytik Jena Business Overview Table 71. Analytik Jena Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Analytik Jena Blood & Tissue Kit Product Portfolio Table 73. Analytik Jena Recent Development Table 74. Axygen (Corning) Company Information Table 75. Axygen (Corning) Business Overview Table 76. Axygen (Corning) Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Axygen (Corning) Blood & Tissue Kit Product Portfolio Table 78. Axygen (Corning) Recent Development Table 79. Bio-Rad Company Information Table 80. Bio-Rad Business Overview Table 81. Bio-Rad Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Bio-Rad Blood & Tissue Kit Product Portfolio Table 83. Bio-Rad Recent Development Table 84. BioVision Company Information Table 85. BioVision Business Overview Table 86. BioVision Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. BioVision Blood & Tissue Kit Product Portfolio Table 88. BioVision Recent Development Table 89. Geneaid Company Information Table 90. Geneaid Business Overview Table 91. Geneaid Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Geneaid Blood & Tissue Kit Product Portfolio Table 93. Geneaid Recent Development Table 94. Illumina Company Information Table 95. Illumina Business Overview Table 96. Illumina Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Illumina Blood & Tissue Kit Product Portfolio Table 98. Illumina Recent Development Table 99. Lucigen (Biosearch Technologies) Company Information Table 100. Lucigen (Biosearch Technologies) Business Overview Table 101. Lucigen (Biosearch Technologies) Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Lucigen (Biosearch Technologies) Blood & Tissue Kit Product Portfolio Table 103. Lucigen (Biosearch Technologies) Recent Development Table 104. Macherey-Nagel Company Information Table 105. Macherey-Nagel Business Overview Table 106. Macherey-Nagel Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Macherey-Nagel Blood & Tissue Kit Product Portfolio Table 108. Macherey-Nagel Recent Development Table 109. Norgen Company Information Table 110. Norgen Business Overview Table 111. Norgen Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Norgen Blood & Tissue Kit Product Portfolio Table 113. Norgen Recent Development Table 114. Omega Bio-tek Company Information Table 115. Omega Bio-tek Business Overview Table 116. Omega Bio-tek Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Omega Bio-tek Blood & Tissue Kit Product Portfolio Table 118. Omega Bio-tek Recent Development Table 119. Promega Company Information Table 120. Promega Business Overview Table 121. Promega Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Promega Blood & Tissue Kit Product Portfolio Table 123. Promega Recent Development Table 124. Sigma-Aldrich (Merck) Company Information Table 125. Sigma-Aldrich (Merck) Business Overview Table 126. Sigma-Aldrich (Merck) Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Sigma-Aldrich (Merck) Blood & Tissue Kit Product Portfolio Table 128. Sigma-Aldrich (Merck) Recent Development Table 129. Zymo Research Company Information Table 130. Zymo Research Business Overview Table 131. Zymo Research Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Zymo Research Blood & Tissue Kit Product Portfolio Table 133. Zymo Research Recent Development Table 134. MGI Tech Co., Ltd. Company Information Table 135. MGI Tech Co., Ltd. Business Overview Table 136. MGI Tech Co., Ltd. Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. MGI Tech Co., Ltd. Blood & Tissue Kit Product Portfolio Table 138. MGI Tech Co., Ltd. Recent Development Table 139. Roche Company Information Table 140. Roche Business Overview Table 141. Roche Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Roche Blood & Tissue Kit Product Portfolio Table 143. Roche Recent Development Table 144. Thermo Fisher Scientific Company Information Table 145. Thermo Fisher Scientific Business Overview Table 146. Thermo Fisher Scientific Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Thermo Fisher Scientific Blood & Tissue Kit Product Portfolio Table 148. Thermo Fisher Scientific Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Blood & Tissue Kit Distributors List Table 152. Blood & Tissue Kit Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Blood & Tissue Kit Product Image Figure 2. Global Blood & Tissue Kit Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood & Tissue Kit Sales Value (2021-2032) & (US$ Million) Figure 4. Global Blood & Tissue Kit Sales (2021-2032) & (K Units) Figure 5. Global Blood & Tissue Kit Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Blood & Tissue Kit Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Buffy Coat Image Figure 10. Whole Blood Image Figure 11. Plasma or Serum Image Figure 12. Global Blood & Tissue Kit Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Blood & Tissue Kit Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Blood & Tissue Kit Sales Volume Share by Type (2021-2032) Figure 15. Global Blood & Tissue Kit Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Blood & Tissue Kit Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Blood & Tissue Kit Sales Value Share by Type (2021-2032) Figure 18. R&D Organisations Image Figure 19. Biotechnology Companies Image Figure 20. Global Blood & Tissue Kit Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Blood & Tissue Kit Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Blood & Tissue Kit Sales Volume Share by Application (2021-2032) Figure 23. Global Blood & Tissue Kit Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Blood & Tissue Kit Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Blood & Tissue Kit Sales Value Share by Application (2021-2032) Figure 26. Global Blood & Tissue Kit Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Blood & Tissue Kit Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Blood & Tissue Kit Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Blood & Tissue Kit Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Blood & Tissue Kit Sales Value (2021-2032) & (US$ Million) Figure 31. North America Blood & Tissue Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Blood & Tissue Kit Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Blood & Tissue Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Blood & Tissue Kit Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Blood & Tissue Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Blood & Tissue Kit Sales Value (2021-2032) & (US$ Million) Figure 37. South America Blood & Tissue Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Blood & Tissue Kit Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Blood & Tissue Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Blood & Tissue Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Blood & Tissue Kit Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Blood & Tissue Kit Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Buffy Coat
  • Whole Blood
  • Plasma or Serum
Applications
  • R&D Organisations
  • Biotechnology Companies
Companies covered
  • QIAGEN
  • Analytik Jena
  • Axygen (Corning)
  • Bio-Rad
  • BioVision
  • Geneaid
  • Illumina
  • Lucigen (Biosearch Technologies)
  • Macherey-Nagel
  • Norgen
  • Omega Bio-tek
  • Promega
  • Sigma-Aldrich (Merck)
  • Zymo Research
  • MGI Tech Co., Ltd.
  • Roche
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Blood & Tissue Kit Sales Value (2021-2032)
  4. 1.2.2 Global Blood & Tissue Kit Sales Volume (2021-2032)
  5. 1.2.3 Global Blood & Tissue Kit Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Blood & Tissue Kit Market Dynamics
  1. 2.1 Blood & Tissue Kit Industry Trends
  2. 2.2 Blood & Tissue Kit Industry Drivers
  3. 2.3 Blood & Tissue Kit Industry Opportunities and Challenges
  4. 2.4 Blood & Tissue Kit Industry Restraints
3 Blood & Tissue Kit Market by Company
  1. 3.1 Global Blood & Tissue Kit Company Revenue Ranking in 2025
  2. 3.2 Global Blood & Tissue Kit Revenue by Company (2021-2026)
  3. 3.3 Global Blood & Tissue Kit Sales Volume by Company (2021-2026)
  4. 3.4 Global Blood & Tissue Kit Average Price by Company (2021-2026)
  5. 3.5 Global Blood & Tissue Kit Company Ranking (2024-2026)
  6. 3.6 Global Blood & Tissue Kit Company Manufacturing Base and Headquarters
  7. 3.7 Global Blood & Tissue Kit Company Product Type and Application
  8. 3.8 Global Blood & Tissue Kit Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Blood & Tissue Kit Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Blood & Tissue Kit Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Blood & Tissue Kit Market by Type
  1. 4.1 Blood & Tissue Kit Type Introduction
  2. 4.1.1 Buffy Coat
  3. 4.1.2 Whole Blood
  4. 4.1.3 Plasma or Serum
  5. 4.2 Global Blood & Tissue Kit Sales Volume by Type
  6. 4.2.1 Global Blood & Tissue Kit Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Blood & Tissue Kit Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Blood & Tissue Kit Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Blood & Tissue Kit Sales Value by Type
  10. 4.3.1 Global Blood & Tissue Kit Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Blood & Tissue Kit Sales Value by Type (2021-2032)
  12. 4.3.3 Global Blood & Tissue Kit Sales Value Share by Type (2021-2032)
5 Blood & Tissue Kit Market by Application
  1. 5.1 Blood & Tissue Kit Application Introduction
  2. 5.1.1 R&D Organisations
  3. 5.1.2 Biotechnology Companies
  4. 5.2 Global Blood & Tissue Kit Sales Volume by Application
  5. 5.2.1 Global Blood & Tissue Kit Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Blood & Tissue Kit Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Blood & Tissue Kit Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Blood & Tissue Kit Sales Value by Application
  9. 5.3.1 Global Blood & Tissue Kit Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Blood & Tissue Kit Sales Value by Application (2021-2032)
  11. 5.3.3 Global Blood & Tissue Kit Sales Value Share by Application (2021-2032)
6 Blood & Tissue Kit Regional Sales and Value Analysis
  1. 6.1 Global Blood & Tissue Kit Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood & Tissue Kit Sales by Region (2021-2032)
  3. 6.2.1 Global Blood & Tissue Kit Sales by Region: 2021-2026
  4. 6.2.2 Global Blood & Tissue Kit Sales by Region (2027-2032)
  5. 6.3 Global Blood & Tissue Kit Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Blood & Tissue Kit Sales Value by Region (2021-2032)
  7. 6.4.1 Global Blood & Tissue Kit Sales Value by Region: 2021-2026
  8. 6.4.2 Global Blood & Tissue Kit Sales Value by Region (2027-2032)
  9. 6.5 Global Blood & Tissue Kit Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Blood & Tissue Kit Sales Value (2021-2032)
  12. 6.6.2 North America Blood & Tissue Kit Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Blood & Tissue Kit Sales Value (2021-2032)
  15. 6.7.2 Europe Blood & Tissue Kit Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Blood & Tissue Kit Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Blood & Tissue Kit Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Blood & Tissue Kit Sales Value (2021-2032)
  21. 6.9.2 South America Blood & Tissue Kit Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Blood & Tissue Kit Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Blood & Tissue Kit Sales Value Share by Country, 2025 VS 2032
7 Blood & Tissue Kit Country-level Sales and Value Analysis
  1. 7.1 Global Blood & Tissue Kit Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blood & Tissue Kit Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Blood & Tissue Kit Sales by Country (2021-2032)
  4. 7.3.1 Global Blood & Tissue Kit Sales by Country (2021-2026)
  5. 7.3.2 Global Blood & Tissue Kit Sales by Country (2027-2032)
  6. 7.4 Global Blood & Tissue Kit Sales Value by Country (2021-2032)
  7. 7.4.1 Global Blood & Tissue Kit Sales Value by Country (2021-2026)
  8. 7.4.2 Global Blood & Tissue Kit Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Blood & Tissue Kit Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Blood & Tissue Kit Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Blood & Tissue Kit Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 QIAGEN
  2. 8.1.1 QIAGEN Company Information
  3. 8.1.2 QIAGEN Business Overview
  4. 8.1.3 QIAGEN Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 QIAGEN Blood & Tissue Kit Product Portfolio
  6. 8.1.5 QIAGEN Recent Developments
  7. 8.2 Analytik Jena
  8. 8.2.1 Analytik Jena Company Information
  9. 8.2.2 Analytik Jena Business Overview
  10. 8.2.3 Analytik Jena Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Analytik Jena Blood & Tissue Kit Product Portfolio
  12. 8.2.5 Analytik Jena Recent Developments
  13. 8.3 Axygen (Corning)
  14. 8.3.1 Axygen (Corning) Company Information
  15. 8.3.2 Axygen (Corning) Business Overview
  16. 8.3.3 Axygen (Corning) Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Axygen (Corning) Blood & Tissue Kit Product Portfolio
  18. 8.3.5 Axygen (Corning) Recent Developments
  19. 8.4 Bio-Rad
  20. 8.4.1 Bio-Rad Company Information
  21. 8.4.2 Bio-Rad Business Overview
  22. 8.4.3 Bio-Rad Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bio-Rad Blood & Tissue Kit Product Portfolio
  24. 8.4.5 Bio-Rad Recent Developments
  25. 8.5 BioVision
  26. 8.5.1 BioVision Company Information
  27. 8.5.2 BioVision Business Overview
  28. 8.5.3 BioVision Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BioVision Blood & Tissue Kit Product Portfolio
  30. 8.5.5 BioVision Recent Developments
  31. 8.6 Geneaid
  32. 8.6.1 Geneaid Company Information
  33. 8.6.2 Geneaid Business Overview
  34. 8.6.3 Geneaid Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Geneaid Blood & Tissue Kit Product Portfolio
  36. 8.6.5 Geneaid Recent Developments
  37. 8.7 Illumina
  38. 8.7.1 Illumina Company Information
  39. 8.7.2 Illumina Business Overview
  40. 8.7.3 Illumina Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Illumina Blood & Tissue Kit Product Portfolio
  42. 8.7.5 Illumina Recent Developments
  43. 8.8 Lucigen (Biosearch Technologies)
  44. 8.8.1 Lucigen (Biosearch Technologies) Company Information
  45. 8.8.2 Lucigen (Biosearch Technologies) Business Overview
  46. 8.8.3 Lucigen (Biosearch Technologies) Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lucigen (Biosearch Technologies) Blood & Tissue Kit Product Portfolio
  48. 8.8.5 Lucigen (Biosearch Technologies) Recent Developments
  49. 8.9 Macherey-Nagel
  50. 8.9.1 Macherey-Nagel Company Information
  51. 8.9.2 Macherey-Nagel Business Overview
  52. 8.9.3 Macherey-Nagel Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Macherey-Nagel Blood & Tissue Kit Product Portfolio
  54. 8.9.5 Macherey-Nagel Recent Developments
  55. 8.10 Norgen
  56. 8.10.1 Norgen Company Information
  57. 8.10.2 Norgen Business Overview
  58. 8.10.3 Norgen Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Norgen Blood & Tissue Kit Product Portfolio
  60. 8.10.5 Norgen Recent Developments
  61. 8.11 Omega Bio-tek
  62. 8.11.1 Omega Bio-tek Company Information
  63. 8.11.2 Omega Bio-tek Business Overview
  64. 8.11.3 Omega Bio-tek Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Omega Bio-tek Blood & Tissue Kit Product Portfolio
  66. 8.11.5 Omega Bio-tek Recent Developments
  67. 8.12 Promega
  68. 8.12.1 Promega Company Information
  69. 8.12.2 Promega Business Overview
  70. 8.12.3 Promega Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Promega Blood & Tissue Kit Product Portfolio
  72. 8.12.5 Promega Recent Developments
  73. 8.13 Sigma-Aldrich (Merck)
  74. 8.13.1 Sigma-Aldrich (Merck) Company Information
  75. 8.13.2 Sigma-Aldrich (Merck) Business Overview
  76. 8.13.3 Sigma-Aldrich (Merck) Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sigma-Aldrich (Merck) Blood & Tissue Kit Product Portfolio
  78. 8.13.5 Sigma-Aldrich (Merck) Recent Developments
  79. 8.14 Zymo Research
  80. 8.14.1 Zymo Research Company Information
  81. 8.14.2 Zymo Research Business Overview
  82. 8.14.3 Zymo Research Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Zymo Research Blood & Tissue Kit Product Portfolio
  84. 8.14.5 Zymo Research Recent Developments
  85. 8.15 MGI Tech Co., Ltd.
  86. 8.15.1 MGI Tech Co., Ltd. Company Information
  87. 8.15.2 MGI Tech Co., Ltd. Business Overview
  88. 8.15.3 MGI Tech Co., Ltd. Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 MGI Tech Co., Ltd. Blood & Tissue Kit Product Portfolio
  90. 8.15.5 MGI Tech Co., Ltd. Recent Developments
  91. 8.16 Roche
  92. 8.16.1 Roche Company Information
  93. 8.16.2 Roche Business Overview
  94. 8.16.3 Roche Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Roche Blood & Tissue Kit Product Portfolio
  96. 8.16.5 Roche Recent Developments
  97. 8.17 Thermo Fisher Scientific
  98. 8.17.1 Thermo Fisher Scientific Company Information
  99. 8.17.2 Thermo Fisher Scientific Business Overview
  100. 8.17.3 Thermo Fisher Scientific Blood & Tissue Kit Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Thermo Fisher Scientific Blood & Tissue Kit Product Portfolio
  102. 8.17.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Blood & Tissue Kit Value Chain Analysis
  2. 9.1.1 Blood & Tissue Kit Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Blood & Tissue Kit Sales Mode & Process
  6. 9.2 Blood & Tissue Kit Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Blood & Tissue Kit Distributors
  9. 9.2.3 Blood & Tissue Kit Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst